South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...
The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...
Image Caption: Representatives from Sanofi, A*STAR, the National Skin Centre and National Healthcare Group alo...
Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...
SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, a promising R&D bio...
Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...
Singapore Health Sciences Authority (HSA) has approved the Pfizer's bivalent vaccine, Abryvso, for active immu...
The World Health Organization (WHO) has announced MVA-BN vaccine as the first vaccine against mpox to be added to its pr...
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...
Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
Danish firm Bavarian Nordic A/S has announced that Singapore’s medicines regulatory authority, Health Sciences Aut...
A new facility at The University of Queensland (UQ) is set to provide Australian researchers with cancer vaccines tailor...
Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...
